Application Note: WB: 0.2-1μg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 16
Positive Control: The peptide used to generate this antibody is available for purchase (GTX89925-PEP).
Specificity/Sensitivity: This antibody is also expected to recognize the readthrough transcript product KUA-UEV (NP_954673.1, GeneID 387522). Also cross-reactivity is expected with UEV2V1 (GeneID 7335).
Form: Liquid
Buffer (with preservative): TBS, 0.5% BSA, 0.02% Sodium azide.
Concentration: 0.50 mg/ml (Please refer to the vial label for the specific concentration.)
Background: Ubiquitin-conjugating enzyme E2 variant proteins constitute a distinct subfamily within the E2 protein family. They have sequence similarity to other ubiquitin-conjugating enzymes but lack the conserved cysteine residue that is critical for the catalytic activity of E2s. The protein encoded by this gene also shares homology with ubiquitin-conjugating enzyme E2 variant 1 and yeast MMS2 gene product. It may be involved in the differentiation of monocytes and enterocytes. [provided by RefSeq, Jul 2008]
Uniprot ID: Q15819
Antigen Species: Human
Immunogen: Peptide with sequence AVSTGVKVPRNF-C, from the N Terminus of the protein sequence according to NP_003341.1; NP_954673.1.
Purification: Purified by ammonium sulphate precipitation followed by antigen affinity chromatography
Conjugation: Unconjugated
Full Name: ubiquitin conjugating enzyme E2 V2
English
Deutsch
